BM
AMRX icon

Bridger Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Bridger Management’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,021,420
Closed -$13.8M – 34
2018
Q4 		$13.8M Sell
1,021,420
-1,621,201
-61% -$29.2M 1.15% 32
2018
Q3 		$58.6M Buy
2,642,621
+499,000
+23% +$10.5M 3.39% 14
2018
Q2 		$35.2M Buy
+2,143,621
New +$37.6M 1.91% 25

Other funds holding AMRX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bridger Management's AMRX Position: Q1 2019 in Review

Bridger Management sold out of Amneal Pharmaceuticals (AMRX) in Q1 2019, closing a stake of 1,021,420 shares — an estimated $13.8M sold.

Bridger Management first reported a position in AMRX in Q2 2018 and held it in 3 quarters. The position peaked at $58.6M in Q3 2018. 164 funds tracked by Wall St. Rank hold AMRX as of Q1 2019.

  • Bridger Management reported no remaining Amneal Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Bridger Management sold 1,021,420 Amneal Pharmaceuticals shares in Q1 2019, an estimated $13.8M.
  • Bridger Management first reported a position in Amneal Pharmaceuticals in Q2 2018 and held it in 3 quarters.
  • Bridger Management's Amneal Pharmaceuticals position peaked at $58.6M in Q3 2018.
  • 164 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2019.

Based on Bridger Management's 13F filing for Q1 2019, filed 15 May 2019.